fbpx

Picato Gel Alleged to Be “Worthless” Complaint

April 29, 2021

Does Picato gel increase the risk of squamous cell skin cancer? The complaint for this class action says it does and declares the medicine “defectively manufactured and unfit for [its] intended purpose[.]” It brings suit against LEO Pharma, Inc. and LEO Pharma AS for breach of the implied warranty of merchantability, claiming that Picato is “worthless.”

Case Event File: Picato Gel Alleged to Be “Worthless” Complaint

Related to: Picato Gel Alleged to Be “Worthless” Class Action